Literature DB >> 16763188

Intrinsic activated microglia map to the peri-infarct zone in the subacute phase of ischemic stroke.

Christopher J S Price1, Dechao Wang, David K Menon, Joe V Guadagno, Marcel Cleij, Tim Fryer, Franklin Aigbirhio, Jean-Claude Baron, Elizabeth A Warburton.   

Abstract

BACKGROUND AND
PURPOSE: Microglial activation is an important component of the neuroinflammatory response to ischemic stroke. Experimental studies have outlined such patterns temporally and spatially. In vivo studies in stroke patients have relied on positron emission tomography and (R)-PK11195, a ligand that binds peripheral benzodiazepine binding sites. In this study we sought to establish temporal and spatial patterns of microglial activation in ischemic stroke with particular emphasis on a defined peri-infarct zone.
METHODS: Using this technique, we studied carotid territory ischemic stroke patients in 3 time windows up to 30 days after ictus. Controls were studied in a single session. [11C](R)-PK11195 injection was followed by 3-dimensional acquisition over 60 minutes. Cerebral blood volume (CBV) was measured afterward with the use of standard C15O paradigms. Analysis employed the reference tissue model in which ipsilateral cerebellum was used to generate parametric binding potential maps corrected for CBV. Data were coregistered to T1-based MRI. Using control data to identify 99% confidence limits, a region of interest analysis was applied to identify significant binding in core infarction, contralateral hemisphere, and within a defined peri-infarct zone.
RESULTS: Four patients (mean age, 66 years) were imaged across 9 sessions. Four age-matched controls were studied. Within this model, ipsilateral cerebellum was validated as a reference tissue. With the use of control-derived confidence limits and correction for CBV, significant binding potential rises were identified beyond 72 hours and extending to 30 days in core infarction, contralateral hemisphere, and peri-infarct zone.
CONCLUSIONS: In ischemic stroke patients, minimal activation of microglia is seen before 72 hours. Beyond this, binding potential rises in core infarction, peri-infarct zone, and contralateral hemisphere to 30 days. This may represent a therapeutic opportunity that extends beyond time windows traditionally reserved for neuroprotection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763188     DOI: 10.1161/01.STR.0000226980.95389.0b

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  63 in total

Review 1.  The development, past achievements, and future directions of brain PET.

Authors:  Terry Jones; Eugenii A Rabiner
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-21       Impact factor: 6.200

2.  The KCa3.1 blocker TRAM-34 reduces infarction and neurological deficit in a rat model of ischemia/reperfusion stroke.

Authors:  Yi-Je Chen; Girija Raman; Silke Bodendiek; Martha E O'Donnell; Heike Wulff
Journal:  J Cereb Blood Flow Metab       Date:  2011-07-13       Impact factor: 6.200

3.  Inflammation after stroke: mechanisms and therapeutic approaches.

Authors:  Muzamil Ahmad; Steven H Graham
Journal:  Transl Stroke Res       Date:  2010-06       Impact factor: 6.829

Review 4.  Positron emission tomography imaging of neuroinflammation.

Authors:  Annachiara Cagnin; Michael Kassiou; Steve R Meikle; Richard B Banati
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

Review 5.  Imaging microglial activation during neuroinflammation and Alzheimer's disease.

Authors:  Sriram Venneti; Clayton A Wiley; Julia Kofler
Journal:  J Neuroimmune Pharmacol       Date:  2008-12-04       Impact factor: 4.147

6.  The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders.

Authors:  Sriram Venneti; Guoji Wang; Jason Nguyen; Clayton A Wiley
Journal:  J Neuropathol Exp Neurol       Date:  2008-10       Impact factor: 3.685

7.  Transient focal ischemia results in persistent and widespread neuroinflammation and loss of glutamate NMDA receptors.

Authors:  Jasbeer Dhawan; Helene Benveniste; Marta Nawrocky; S David Smith; Anat Biegon
Journal:  Neuroimage       Date:  2010-03-04       Impact factor: 6.556

Review 8.  Role of cortical spreading depression in the pathophysiology of migraine.

Authors:  Yilong Cui; Yosky Kataoka; Yasuyoshi Watanabe
Journal:  Neurosci Bull       Date:  2014-09-28       Impact factor: 5.203

9.  Noggin protects against ischemic brain injury in rodents.

Authors:  Jayshree Samanta; Tord Alden; Kevin Gobeske; Lixin Kan; John A Kessler
Journal:  Stroke       Date:  2009-12-17       Impact factor: 7.914

Review 10.  Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers.

Authors:  Fabien Chauveau; Hervé Boutin; Nadja Van Camp; Frédéric Dollé; Bertrand Tavitian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10-01       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.